When Ipsen announced last week that it wanted in on Exelixis’ Cabometyx for thyroid cancer, the company pegged that move to the oncology drug’s promising late-stage trial results. Now, Exelixis is offering up more details of that very trial. For a phase 3 study up for presentation at the virtual American Society of Clinical Oncology meeting, investigators… Read More »
Big Six have lost 8 percent of market to challenger brands in three years Good customer service still the key to consumer trust Price remains the most important factor when choosing to switch provider Green credentials increasingly important for consumers wanting to switch 70 percent of 18-34 year olds want energy conservation advice Email still… Read More »
Health tech usage may have accelerated during the COVID-19 pandemic, but it only helped alleviate clinicians’ stress if it was installed before the outbreak, according to a new study. Research carried out by HIMSS and UK med tech firm Nuance Communications found 97% of doctors and 99% of nurses surveyed had experienced burnout at some… Read More »
After being the epicenter of a devastating second wave, India’s wealthiest state is already taking steps to prepare for a possible third wave, according to its tourism and environment minister. The western state of Maharashtra, home to India’s financial capital Mumbai, has so far reported more than 5.4 million cases, including over 82,000 deaths from… Read More »